Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 429

1.

Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study.

Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J.

Lancet Infect Dis. 2012 Sep;12(9):696-702. doi: 10.1016/S1473-3099(12)70133-0. Epub 2012 Jun 26.

PMID:
22738894
2.

Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.

Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J.

Health Technol Assess. 2010 Jul;14(34):313-46. doi: 10.3310/hta14340-05.

3.

Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.

Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K.

BMJ. 2011 Jan 25;344:d7901. doi: 10.1136/bmj.d7901.

4.

Early estimation of pandemic influenza Antiviral and Vaccine Effectiveness (EAVE): use of a unique community and laboratory national data-linked cohort study.

Simpson CR, Lone N, McMenamin J, Gunson R, Robertson C, Ritchie LD, Sheikh A.

Health Technol Assess. 2015 Oct;19(79):1-32. doi: 10.3310/hta19790.

5.

A population based cohort study to assess the safety of pandemic influenza vaccine Focetria in Emilia-Romagna region, Italy - part two.

Moro ML, Nobilio L, Voci C, Di Mario S, Candela S, Magrini N; SaFoH1N1 working group.

Vaccine. 2013 Feb 27;31(10):1438-46. doi: 10.1016/j.vaccine.2012.07.090. Epub 2012 Aug 10.

PMID:
22885015
6.

Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.

Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, van der Werf S, Cohen JM, Lina B, Blanchon T, Hanslik T.

PLoS One. 2011 May 10;6(5):e19621. doi: 10.1371/journal.pone.0019621.

7.

Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case-control study.

Castilla J, Morán J, Martínez-Artola V, Fernández-Alonso M, Guevara M, Cenoz MG, Reina G, Alvarez N, Arriazu M, Elía F, Salcedo E, Barricarte A; Primary Health Care Sentinel Network of Navarre.

Vaccine. 2011 Aug 11;29(35):5919-24. doi: 10.1016/j.vaccine.2011.06.063. Epub 2011 Jun 30.

PMID:
21723358
8.

Usefulness of health registries when estimating vaccine effectiveness during the influenza A(H1N1)pdm09 pandemic in Norway.

Guzmán Herrador BR, Aavitsland P, Feiring B, Riise Bergsaker MA, Borgen K.

BMC Infect Dis. 2012 Mar 20;12:63. doi: 10.1186/1471-2334-12-63.

9.

Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010.

Hardelid P, Fleming DM, McMenamin J, Andrews N, Robertson C, SebastianPillai P, Ellis J, Carman W, Wreghitt T, Watson JM, Pebody RG.

Euro Surveill. 2011 Jan 13;16(2). pii: 19763.

10.

Pandemic influenza A(H1N1)pdm09 improves vaccination routine in subsequent years: a cohort study from 2009 to 2011.

Tacken MA, Jansen B, Mulder J, Visscher S, Heijnen ML, Campbell SM, Braspenning JC.

Vaccine. 2013 Jan 30;31(6):900-5. doi: 10.1016/j.vaccine.2012.12.002. Epub 2012 Dec 16.

PMID:
23246546
11.

Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Hellenbrand W, Jorgensen P, Schweiger B, Falkenhorst G, Nachtnebel M, Greutélaers B, Traeder C, Wichmann O.

BMC Infect Dis. 2012 May 31;12:127. doi: 10.1186/1471-2334-12-127.

12.

Uptake and effectiveness of monovalent influenza A (H1N1) pandemic 2009 vaccine among healthcare personnel in Kenya, 2010.

Njuguna H, Ahmed J, Oria PA, Arunga G, Williamson J, Kosgey A, Muthoka P, Mott JA, Breiman RF, Katz MA.

Vaccine. 2013 Sep 23;31(41):4662-7. doi: 10.1016/j.vaccine.2013.07.005. Epub 2013 Jul 13.

PMID:
23859843
13.

Effectiveness of the pandemic H1N1 influenza vaccines against laboratory-confirmed H1N1 infections: population-based case-control study.

Mahmud S, Hammond G, Elliott L, Hilderman T, Kurbis C, Caetano P, Van Caeseele P, Kettner J, Dawood M.

Vaccine. 2011 Oct 19;29(45):7975-81. doi: 10.1016/j.vaccine.2011.08.068. Epub 2011 Aug 30.

PMID:
21884747
14.

Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.

Fielding JE, Grant KA, Garcia K, Kelly HA.

Emerg Infect Dis. 2011 Jul;17(7):1181-7. doi: 10.3201/eid1707.101959.

15.

Effectiveness of a MF-59™-adjuvanted pandemic influenza vaccine to prevent 2009 A/H1N1 influenza-related hospitalisation; a matched case-control study.

Steens A, Wijnans EG, Dieleman JP, Sturkenboom MC, van der Sande MA, van der Hoek W.

BMC Infect Dis. 2011 Jul 18;11:196. doi: 10.1186/1471-2334-11-196.

16.

Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England.

Andrews N, Waight P, Yung CF, Miller E.

J Infect Dis. 2011 Jan 1;203(1):32-9. doi: 10.1093/infdis/jiq014.

17.
18.

Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.

Puleston RL, Bugg G, Hoschler K, Konje J, Thornton J, Stephenson I, Myles P, Enstone J, Augustine G, Davis Y, Zambon M, Nicholson KG, Nguyen-Van-Tam JS.

Health Technol Assess. 2010 Dec;14(55):1-82. doi: 10.3310/hta14550-01.

19.

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: a population-based test-negative case-control study.

Martínez-Baz I, Martínez-Artola V, Reina G, Guevara M, Cenoz MG, Morán J, Irisarri F, Arriazu M, Albeniz E, Castilla J; Primary Health Care Sentinel Network of Navarre.

BMC Public Health. 2013 Mar 6;13:191. doi: 10.1186/1471-2458-13-191.

20.

No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.

Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, Miller E.

Vaccine. 2011 Mar 21;29(14):2613-8. doi: 10.1016/j.vaccine.2011.01.046. Epub 2011 Feb 1.

PMID:
21292008

Supplemental Content

Support Center